Pembrolizumab effective as post-nephrectomy adjuvant therapy in clear cell renal cell carcinoma: LANCET Dr.Niharika Harsha B12 April 2023 4:00 AM GMTUpdated results from the KEYNOTE-564 trial showed that pembrolizumab monotherapy can be used as a standard of care for patients with renal...
Preoperative circulating markers of systemic inflammatory response may predict prognosis in primary operable breast cancer Dr.Niharika Harsha B7 Oct 2022 2:00 PM GMTA systematic review and meta-analysis of the current literature were performed to assess the role of clinically commonly available systemic...
Laparo-Assisted Vaginal Hysterectomy safe option to Abdominal Radical Hysterectomy in Early Cervical Cancer Medical Dialogues Editorial Team15 May 2022 4:00 PM GMTA new study published in Gynecologic Oncology reveals that Laparo-Assisted Vaginal Hysterectomy could represent a valid and safe option to...
Add on COX-2 inhibitors do not Improve Survival in Patients with CRC: JAMA MD Bureau7 April 2021 11:36 AM GMTAspirin and cyclooxygenase 2 (COX-2) inhibitors have been associated with a reduced risk of colorectal polyps and cancer in observational and...
Metformin and Vitamin D Improve Clinical Outcomes of Cholangiocarcinoma: Study MD Bureau1 March 2021 12:15 AM GMTCholangiocarcinoma (CCA) is the most common biliary malignancy and the second most common hepatic malignancy after hepatocellular carcinoma (HCC). A...
Tamoxifen improves survival in male breast cancer patients, finds study Medha Baranwal28 July 2020 3:15 PM GMTGermany: Tamoxifen treatment improves disease-free survival (DFS) in male breast cancer (MBC) patients, suggests a recent study in the British Journal...
